K-115 phase 2 dose-respopnse study

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080220982

Enrollment

200

Registered

2010-01-27

Start date

2010-01-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

POAG or OH

Interventions

investigational material(s) Generic name etc : K-115 INN of investigational material : Therapeutic category code : 131 Agents for ophthalmic use Dosage and Administration for Investigational material

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: POAG or OH patients

Exclusion criteria

Exclusion criteria: 1.Patients whose visual acuity is below 0.3 2.Patients thought to use glaucoma medication 3.Patients thought to wear contact lenses etc.

Design outcomes

Primary

Measure	Time frame
Efficacy, safety Intraocular pressure, adverse event	—

Secondary

Measure	Time frame
Efficacy, safety Intraocular pressure, adverse event	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026